Similarly, in case of patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody, MMP-9 and TIMP-1 seem to have lost their prognostic value [27]. This evidence concerns the gene TIMP1 and diffuse large B-cell lymphoma.